Development of novel theranostic agents for in vivo amyloid imaging and protective effects on human neuroblastoma cells - Archive ouverte HAL Accéder directement au contenu
Article Dans Une Revue European Journal of Medicinal Chemistry Année : 2019

Development of novel theranostic agents for in vivo amyloid imaging and protective effects on human neuroblastoma cells

Résumé

Brain amyloid deposits have been identified as the main neuropathological hallmarks of Alzheimer's diseases (AD) and intensive efforts have been devoted to develop aggregation inhibitors preventing the formation of toxic oligomeric Aβ for therapeutic. In addition, evidence indicates that the formation and accumulation of β−amyloid plaques probably precede clinical symptoms by around 20 years and imaging of such plaques would be beneficial for early-stage AD detection. In this study, we investigated phenothiazine-based compounds as novel promising theranostic agents for AD. These multifunctional agents exhibited BBB permeability, low neurotoxicity, good bio-stability as well as strong turn-on fluorescence with a Stokes shift upon binding to Aβ aggregates. They had metal-chelating property which could delay Aβ aggregation and displayed high binding affinity for β−amyloid aggregates. Moreover, they have been simultaneously applied to perform in vivo near-infrared fluorescence imaging of β-amyloid plaques in double transgenic AD mouse model, to prevent self-aggregation of Aβ monomer from forming toxic oligomers and to protect human neuroblastoma SH-SY5Y cells against Aβ-induced toxicity and oxidative stress.
Fichier principal
Vignette du fichier
S0223523419307196.pdf (3.07 Mo) Télécharger le fichier
Origine : Fichiers produits par l'(les) auteur(s)

Dates et versions

hal-02338799 , version 1 (20-07-2022)

Licence

Paternité - Pas d'utilisation commerciale

Identifiants

Citer

Yongliang Li, Longjia Yan, Jing Cai, Wanzheng Zhang, Li Li, et al.. Development of novel theranostic agents for in vivo amyloid imaging and protective effects on human neuroblastoma cells. European Journal of Medicinal Chemistry, 2019, 181, pp.111585. ⟨10.1016/j.ejmech.2019.111585⟩. ⟨hal-02338799⟩
20 Consultations
27 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More